{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:35:31Z","timestamp":1770741331790,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Macau SAR","award":["0052\/2018\/A2"],"award-info":[{"award-number":["0052\/2018\/A2"]}]},{"name":"Macau SAR","award":["0077\/2019\/A2"],"award-info":[{"award-number":["0077\/2019\/A2"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61827819"],"award-info":[{"award-number":["61827819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jpba.2020.113579","type":"journal-article","created":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T19:31:16Z","timestamp":1598124676000},"page":"113579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Rapid and sensitive determination of four bisphosphonates in rat plasma after MTBSTFA derivatization using liquid chromatography-mass spectrometry"],"prefix":"10.1016","volume":"190","author":[{"given":"Hui-Xia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher Wai Kei","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Di","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yun","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113579_bib0005","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/bcp.13867","article-title":"Pharmacology of bisphosphonates","volume":"85","author":"Cremers","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2020.113579_bib0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/bcr414","article-title":"The role of bisphosphonates in breast cancer: development of bisphosphonates","volume":"4","author":"Herbert","year":"2001","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jpba.2020.113579_bib0015","first-page":"265","article-title":"Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro","volume":"14","author":"Yuan","year":"2016","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.jpba.2020.113579_bib0020","series-title":"Bisphosphonates (BPs)","first-page":"187","author":"Bartl","year":"2019"},{"key":"10.1016\/j.jpba.2020.113579_bib0025","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0731-7085(96)02021-3","article-title":"An enzyme inhibition assay for the quantitative determination of the new bisphosphonate zoledronate in plasma","volume":"15","author":"Risser","year":"1997","journal-title":"J. Pharmaceut. Biomed."},{"key":"10.1016\/j.jpba.2020.113579_bib0030","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0731-7085(02)00218-2","article-title":"Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine","volume":"30","author":"Legay","year":"2002","journal-title":"J. Pharmaceut. Biomed."},{"key":"10.1016\/j.jpba.2020.113579_bib0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.aca.2006.01.077","article-title":"Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with UV detector","volume":"562","author":"Jia","year":"2006","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2020.113579_bib0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0378-4347(93)E0397-9","article-title":"Sensitive determination of a novel bisphosphonate, YM529, in plasma, urine and bone by high-performance liquid chromatography with fluorescence detection","volume":"652","author":"Usui","year":"1994","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jpba.2020.113579_bib0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/bmc.298","article-title":"Determination of pamidronate in human whole blood and urine by reversed\u2010phase HPLC with fluorescence detection","volume":"18","author":"Wong","year":"2004","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2020.113579_bib0050","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.4155\/bio.14.223","article-title":"Quantitative analysis of bisphosphonates in biological samples","volume":"6","author":"Veniamin N Lapko","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2020.113579_bib0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.chroma.2007.04.020","article-title":"Development and application of a high-performance liquid chromatography\u2013mass spectrometry method to determine alendronate in human urine","volume":"1160","author":"Tarcomnicu","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2020.113579_bib0060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jpba.2008.05.028","article-title":"Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods","volume":"48","author":"Zacharis","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113579_bib0065","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jchromb.2011.05.037","article-title":"Determination of zoledronic acid in human urine and blood plasma using liquid chromatography\/electrospray mass spectrometry","volume":"879","author":"Veldboer","year":"2011","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2020.113579_bib0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jchromb.2011.11.031","article-title":"Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography\/tandem mass spectrometry (LC-MS\/MS) for determination of risedronate concentrations in human plasma","volume":"881-882","author":"Ghassabian","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2020.113579_bib0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/chromsci\/45.5.236","article-title":"Rapid determination of bisphosphonates by ion chromatography with indirect UV detection","volume":"45","author":"Fernandes","year":"2007","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2020.113579_bib0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3724\/SP.J.1009.2013.00164","article-title":"Development of a hydrophilic interaction chromatography-UPLC assay to determine trigonelline in rat plasma and its application in a pharmacokinetic study","volume":"11","author":"Cheng","year":"2013","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.jpba.2020.113579_bib0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.chroma.2014.09.016","article-title":"A novel automated hydrophilic interaction liquid chromatography method using diode-array detector\/electrospray ionization tandem mass spectrometry for analysis of sodium risedronate and related degradation products in pharmaceuticals","volume":"1365","author":"Bertolini","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2020.113579_bib0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/separations6010006","article-title":"Insights into the mechanism of separation of bisphosphonates by zwitterionic hydrophilic interaction liquid chromatography: application to the quantitation of risedronate in pharmaceuticals","volume":"6","author":"Panderi","year":"2019","journal-title":"Separations"},{"key":"10.1016\/j.jpba.2020.113579_bib0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-4347(01)00551-5","article-title":"Determination of alendronate in human urine as 9-fluorenylmethyl derivative by high-performance liquid chromatography","volume":"767","author":"Ptacek","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2020.113579_bib0100","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1016\/j.jchromb.2009.08.007","article-title":"High-throughput HPLC-MS\/MS method to determine ibandronate in human plasma for pharmacokinetic applications","volume":"877","author":"Tarcomnicu","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2020.113579_bib0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jpba.2018.09.042","article-title":"Development and validation of a method using ultra performance liquid chromatography coupled to tandem mass spectrometry for determination of zoledronic acid concentration in human bone","volume":"162","author":"Lo Faro","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113579_bib0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jchromb.2013.07.019","article-title":"Quantitation of zoledronic acid in murine bone by liquid chromatography coupled with tandem mass spectrometry","volume":"935","author":"Raccor","year":"2013","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2020.113579_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2015.06.020","article-title":"Liquid chromatography-mass spectrometry analysis of five bisphosphonates in equine urine and plasma","volume":"998-999","author":"Wong","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2020.113579_bib0120","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jpba.2014.08.022","article-title":"LC-MS\/MS method for the determination of clodronate in human plasma","volume":"100","author":"Hasan","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113579_bib0125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jchromb.2014.03.018","article-title":"HPLC\/ESI-MSn method for non-amino bisphosphonates: application to the detection of tiludronate in equine plasma","volume":"958","author":"Popot","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2020.113579_bib0130","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00216-011-5467-4","article-title":"Trimethylsilyldiazomethane derivatization coupled with solid-phase extraction for the determination of alendronate in human plasma by LC-MS\/MS","volume":"402","author":"Chen","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2020.113579_bib0135","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/jssc.200301492","article-title":"Comparison of silylation and esterification\/acylation procedures in GC-MS analysis of amino acids","volume":"26","author":"Sobolevsky","year":"2003","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2020.113579_bib0140","series-title":"Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation","author":"U.S. Department of Health and Human Services","year":"2018"},{"key":"10.1016\/j.jpba.2020.113579_bib0145","series-title":"Guideline on Bioanalytical Method Validation","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.jpba.2020.113579_bib0150","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2885.2007.00883.x","article-title":"Pharmacokinetics and pharmacodynamics of a single dose of zoledronate in healthy dogs","volume":"30","author":"Martin-Jimenez","year":"2007","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2020.113579_bib0155","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpba.2005.03.020","article-title":"Analytical methods for the quantification of ibandronate in body fluids and bone","volume":"39","author":"Endele","year":"2005","journal-title":"J. Pharmaceut. Biomed."},{"key":"10.1016\/j.jpba.2020.113579_bib0160","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1002\/rcm.2755","article-title":"A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography\/tandem mass spectrometry","volume":"20","author":"Zhu","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2020.113579_bib0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.legalmed.2017.11.003","article-title":"Highly sensitive determination of alendronate in human plasma and dialysate using metal-free HPLC-MS\/MS","volume":"30","author":"Yamada","year":"2018","journal-title":"Leg. Med. (Tokyo)"},{"key":"10.1016\/j.jpba.2020.113579_bib0170","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jpba.2015.05.038","article-title":"On-cartridge derivatization coupled with solid-phase extraction for the ultra-sensitive determination of minodronic acid in human plasma by LC-MS\/MS method","volume":"114","author":"Yang","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113579_bib0175","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1021\/jo9511455","article-title":"Synthesis of hydrolytically stable TBDMS derivatives of Hydroxynaphthoquinones","volume":"61","author":"Maria","year":"1996","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jpba.2020.113579_bib0180","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1002\/rcm.1688","article-title":"Use of 18O3-clodronate as an internal standard for the quantitative analysis of clodronate in human plasma by gas chromatography\/electron ionisation mass spectrometry","volume":"18","author":"Leis","year":"2004","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2020.113579_bib0185","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1021\/acs.analchem.8b04281","article-title":"Method for quantification of ribonucleotides and deoxyribonucleotides in human cells using (Trimethylsilyl)diazomethane derivatization followed by liquid chromatography-tandem mass spectrometry","volume":"91","author":"Li","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2020.113579_bib0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijms.2010.07.017","article-title":"Fragmentation pathways of eight nitrogen-containing bisphosphonates (BPs) investigated by ESI-MSn in negative ion mode","volume":"295","author":"Qu","year":"2010","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2020.113579_bib0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jms.273","article-title":"Electrospray ionization mass spectrometry and tandem mass spectrometry of clodronate and related bisphosphonate and phosphonate compounds","volume":"37","author":"Huikko","year":"2002","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2020.113579_bib0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2018.12.030","article-title":"Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?","volume":"165","author":"Kaza","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113579_bib0205","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2020.113579_bib0210","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jpba.2018.03.052","article-title":"Quantitative evaluation of the matrix effect in bioanalytical methods based on LC\u2013MS: a comparison of two approaches","volume":"155","author":"Rudzki","year":"2018","journal-title":"J. Pharmaceut. Biomed."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520314655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520314655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:10:04Z","timestamp":1760001004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708520314655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":42,"alternative-id":["S0731708520314655"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113579","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid and sensitive determination of four bisphosphonates in rat plasma after MTBSTFA derivatization using liquid chromatography-mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113579"}}